info@marketreportsonchina.com

Pharmaceuticals Industry in China

Press Release   •   Nov 17, 2016 12:21 IST

Market Reports on China presents the report, on “Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide - 2016”. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Synopsis

Essential resource for top-line data and analysis covering the BRIC pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Reasons To Buy

- What was the size of the BRIC pharmaceuticals market by value in 2015?
- What will be the size of the BRIC pharmaceuticals market in 2020?
- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the BRIC pharmaceuticals market?

Key Highlights

- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $155.5 billion in 2015. Russia was the fastest growing country with a CAGR of 21.6% over the 2011-15 period.

- Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $97.9 billion in 2015. This was followed by India, Russia and Brazil with a value of $26.8, $16.9, and $13.9 billion, respectively.

- China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $145.4 billion in 2020, followed by India, Russia, Brazil with expected values of $57.5, $24.9 and $19.2 billion, respectively.

Table of Contents

Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
BRIC Pharmaceuticals
Industry Outlook
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data

Related Reports:China Life Science Market Reports

Contact Us

Market Reports on China

Contact No: India: +91 22 27810773

Email:info@marketreportsonchina.com

Website:http://www.marketreportsonchina.com

Twitter:https://twitter.com/ReportsonChina